Project Consortium

Welcome to iPC

The iPC consortium consists of 21 highly qualified industrial and academic partners from a wide variety of backgrounds and from 11 different countries (Austria, Belgium, Switzerland, Germany, Spain, France, Italy, Netherlands, Slovenia, USA and Australia)

Contact

Technical Lead
María Rodríguez Martínez
IBM Research Switzerland

Get in contact

Scientific Lead
Hans Lehrach
Max-Plank-Institute Germany

Get in contact

Project Coordinator
Klaus-Michael Koch
Technikon
Austria

Get in contact

Blog

15 July, 2019

iPC in a nutshell!

Find out more about identifying effective personalized medicine for paediatric cancer. Comprehensive computational effort to combine knowledge base, machine-learning, and mechanistic models are used in iPC to predict optimal standards and therapies for personalized treatments.